Akèy › Ipèsansibilite arachid › North Carolina
Etid klinik pou Ipèsansibilite arachid nan North Carolina
4 etid pou Ipèsansibilite arachid ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill
Ap rekriteEtid obsèvasyon
12 Months – 17 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT07279467Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
- University of North Carolina at Chapel Hill Clinical and Translational Research Center( CTRC), Chapel Hill
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Jul 28, 2026 · NCT07220811Safety of MOON101 for the Treatment of Peanut Allergy
- University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteFaz 1
Laj 4 a 55 · Tout sèks · Mizajou Jul 14, 2026 · NCT07580898Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.